<a href="https://www.mdpi.com/2073-4425/10/3/218"> Lentiviral Vectors for the Treatment and Prevention of Cystic Fibrosis Lung Disease </a>
<a href="https://pubmed.ncbi.nlm.nih.gov/15564131/">Dual therapeutic utility of proteasome modulating agents for pharmaco-gene therapy of the cystic fibrosis airway</a>
<a href="https://pubmed.ncbi.nlm.nih.gov/14990705/">Distinct classes of proteasome-modulating agents cooperatively augment recombinant adeno-associated virus type 2 and type 5-mediated transduction from the apical surfaces of human airway epithelia</a>
<a href="https://pubmed.ncbi.nlm.nih.gov/25763813/">Optimization of Recombinant Adeno-Associated Virus-Mediated Expression for Large Transgenes, Using a Synthetic Promoter and Tandem Array Enhancers </a>
<a href="https://pubmed.ncbi.nlm.nih.gov/19237554/">Directed evolution of adeno-associated virus to an infectious respiratory virus</a>
<a href="https://spirovant.com/wp-content/uploads/2022/03/NACFC-SP-101_POSTER_Master-9-22-2181-Read-Only-1.pdf">Katherine Excoffon: Delivery of SP-101 restores CFTR function in human CF airway epithelial cultures and drives hCFTRΔR transgene expression in the airways of ferrets. North American Cystic Fibrosis Conference 2021. – Poster</a>
